UBR5 and colorectal carcinoma: One previous study indicated that UBR5 interacts with and upregulates tumor suppressor APC to inhibit the Wnt/β-catenin signaling pathway, indicating that UBR5 could act as a potential tumor suppressor in CRC [83], whereas more studies have suggested that UBR5 functions as an oncoprotein.